Ready to See the Full Patient Journey?
Unlock curated, real-world oncology insights with Patient360™ -- your foundation for faster, more precise evidence generation.
See the Whole Patient. Power Every Decision.
Patient360 is the most deeply curated real-world oncology dataset available - linking EMR, claims, genomics, SDoH, and death date for a 360-degree view of each patient. With over 100 variables per patient and cohort augmentation capabilities, it supports faster, more precise evidence generation. Whether you're modeling outcomes, identifying access gaps, or tracking real-world treatment patterns, Patient360 delivers the insights you need to act.
Key Benefits of ConcertAI's Patient360 Solution
Multimodality
Access the industry's largest real-world EMR oncology dataset -- integrated with claims, genomic, and SDoH data.
.svg)
Curation
Benefit from rapid, machine-supported abstraction with 100+ clinical variables per patient -- research ready from day one.
.svg)
Precision
Uncover in-depth insights and generate evidence in treatment, biomarkers, and outcomes across tumor types that reflect real-world practice -- not just trial conditions.
.svg)
Representativeness
Sourced from oncology practices in Community, Academic, and IDN treatment settings with catchment across all U.S. states.
Core Capabilities of Patient360™
Real-World Evidence Generation
On Demand, On-Target Evidence
- Deeply curated EMR + claims + SDoH
- Rapid cohort creation for targeted studies
- Supports safety, comparative effectiveness, and profiling
- Over 100 curated clinical variables per patient
Line of Therapy & Treatment Mapping
Precision Across the Care Continuum
- Longitudinal tracking from diagnosis through palliative care
- Visualize treatment sequencing and transitions
- Integrates labs, scans, surgery, therapies, and outcomes
- Detect undertreatment, switching patterns, and gaps in care
Cohort Augmentation
Expand Access to Hard-to-Find Patients
- Add patients with specific biomarkers, therapies, or testing
- Fully curated to Patient360 standards
- NGS, PD-L1+, 2L+, rare cancers, and more...
- Enables focused research on subpopulations
Multi-Modal Integration
One Patient, Many Dimensions
- Claims and SDoH enrich EMR-only views
- Linkage to >85% of patients from 2014 onward
- Nationally representative population with payer and site diversity
- Supports payor analysis, adherence, access, and socioeconomic insights
Use Case Highlights
Broad, Real-world Oncology Insights at Scale
Treatment sequencing
reveals how patients transition between standard-of-care and novel therapies across multiple lines, helping uncover real-world patterns and gaps in care.
Timely therapy updates
allow you to evaluate how outcomes vary across treatments, populations, and in contrast to controlled clinical trials.
Biomarker testing
highlights the frequency, timing, and impact of diagnostic tests, enabling better understanding of treatment decisions and personalization.
Economic burden
quantifies the true cost of disease by tracking spend across therapy types, adverse events, providers, and payer categories.
Clinical trial design
is refined by modeling inclusion and exclusion criteria against real-world cohorts to identify practical recruitment strategies.
